News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eli Lilly and Company (LLY) Reports Third-Quarter 2013 Results


10/23/2013 6:50:25 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

INDIANAPOLIS, Oct. 23, 2013 /PRNewswire via COMTEX/ -- -- Worldwide revenue increased 6 percent, driven by solid growth for Cymbalta, insulins, Animal Health, Alimta, Cialis and Trajenta.

-- Higher revenue and ongoing cost containment drove strong operating income growth.

-- Earnings per share totaled $1.11 for the third quarter of 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at Market Watch


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES